Skip to content

Clinical Validation of Boneview for FDA Submission

Clinical Validation of Boneview for FDA Submission: Evaluation of the Ability of the Artificial Intelligence Software, Boneview, to Improve Physicians' and Radiologists' Performances in Detecting Fractures on Bone X-Rays Radiographs.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04532580
Enrollment
480
Registered
2020-08-31
Start date
2020-09-01
Completion date
2021-07-26
Last updated
2021-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fracture

Keywords

fracture, artificial intelligence, x-rays radiographs

Brief summary

The goal of this clinical validation is to assess comparative performances of physicians with and without the assistance of BoneView for the diagnosis of fractures on radiographs. The performances are evaluated in terms of accuracy (primary endpoint with the pair specificity/sensitivity and the secondary endpoint PPV/NPV) and in terms of time needed for diagnosis (secondary endpoint with the measurement of time on each case).

Interventions

DEVICEDiagnosis of fracture on X-Ray Radiographs

Diagnosis of fracture on X-Ray Radiographs with and without the assistance of Boneview Software

Sponsors

Gleamer
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Anonymized standard X-ray exams of extremity/pelvis/rib cage/dorsolumbar spine not containing or containing fracture(s). * Adult patient, with minimum age of 21 years old.

Exclusion criteria

* Exams with one or more images including a body part not concerned by the intended use of BoneView (skull and cervical spine) * Cases with one or more images being used for model design and development. * Exams with one or more images being of poor quality (lossy), which prevent a proper interpretation by the readers. * Cases not containing a medically relevant number of views for correct diagnosis.

Design outcomes

Primary

MeasureTime frameDescription
measurement of diagnosis performances via calculation of sensitivity, specificity, NPV, PPV1 monthcalculation of sensitivity, specificity, NPV, PPV and comparison between the two cohorts

Secondary

MeasureTime frameDescription
Time needed for diagnosis via measurement of the time before submission of the diagnosis1 monthmeasurement of the time and comparison between the two cohorts

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026